Table 7 Correlation between clinical characteristics, human papillomavirus (HPV), and survival
Survival | |||
|---|---|---|---|
Short term, ⩽2 years N (%) | Long term, ⩾8 years N (%) | P -value | |
Histopathological grade | |||
Well | 7 (70) | 3 (30) | 0.072 |
Moderate | 23 (68) | 11 (32) | |
Poor | 9 (39) | 14 (61) | |
Tumour size | |||
<4 cm | 5 (17) | 24 (83) | <0.001 |
4–8 cm | 22 (81) | 5 (19) | |
>8 cm | 12 (100) | 0 (0) | |
FIGO stage | |||
I–II | 23 (49) | 24 (51) | 0.036 |
III–IV | 16 (76) | 5 (24) | |
Local metastasis (tumour growth in septum rectovaginale) | |||
Yes | 6 (100) | 0 (0) | 0.030 |
No | 33 (53) | 29 (47) | |
Regional metastasis (inguinal node metastasis) | |||
Yes | 2 (50) | 2 (50) | 1.00 |
No | 37 (58) | 27 (42) | |
Distant metastasis | |||
Yes | 3 (60) | 2 (40) | 1.00 |
No | 36 (57) | 27 (43) | |
HPV status | |||
Positive | 13 (68) | 6 (32) | 0.18 |
Negative | 12 (48) | 13 (52) | |
